The Proteomic Assessment of Preterm Birth (PAPR) study conducted by Sera Prognostics, Inc. has yielded information that led to the development of a test which can help physicians determine which pregnant patients are at greater risk of having a pre-term birth. The PreTRM test analyzes proteins covering pathways associated with preterm birth, such as stress, inflammation, hemorrhage, uterine over-distention, and more.
The test can be conducted as early as 19 weeks into the pregnancy and can help predict a patient’s percent risk of spontaneous preterm birth (sPTB) before 37 weeks of gestation. Having this risk information early can help physicians develop individualized care plans and give themselves and their patients the peace of mind that they are doing everything they can to protect the pregnancy.
Jill Hechtman, MD, FACOG
Medical Director: Tampa Obstetrics